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  In order to obtain a more adequate therapeutic effect of thioLTEPA for the prevention
of recurrence of bladder cancer， the authors have used the combined vesical lnstillation of
urokinase．
  Herein， cross effects of urokinase and thio－TEPA on their stabilities have been studied
in vitro． Urokinase and thio－TEPA showed no deteriorating effect each other under some
mixing conditions resembling closely the practica1 administration． Macrogol 400 which is









































     実験方法および実験材料
 1． ’fibrinogen： ／ bovine plasminogen－richl fibri－





．2． thrombin ：’D ／b．ovinq thrombin （Thromblh















 6．thio－TEPA測定法：Tan and Cole（1965）8）
により報告されだ方法に準拠して，γ・（4－hitrobenzy！）
pyr dineを用いて測定をおこなった．





















contrel 1．25 2．S5 10 20 P1oug units／ml
 Thio－TEPA ＋ urokinase ； immediately after mixing
●一一一●
 Thio－TEPA ＋ urokinase ； after incubation at 37 ’C for lhr






O IZO min．incubation time at 370C
o一一一一一一一一一一〇
  Tespamin 40 mg ＋ urokinase S，OOO Ploug units
  Tespamin 40 mg ＋ phosphate buffer
Fig． 2． Effect of・urokinase on TespaminO
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Thio－TEPA        le S Z．S 1．2s O．62 o．sl centrol   mg／dl
 十
urokinase        6     6     6     6     6     6     6
 Ploug units／ml
   Fig． 3． Effect of thio－TEPA on urokinase activity．
eentrol 2，5 1．ZS O－62 O．31 Tespamin mg／ml
Tespamin 1 ml ＋ urakinase O．2S ml C312 Ploug units］
Fig． 4． Effect of TespaminO on utokinase





























control 1 2 4 8 16X
   Serial dilution of rnacTogol 400
macrogol 400 sofution 1 rn1 ＋ urokinase O．2S ml｛31Z P1oug uriits）
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